Nanobac gets boost after study shows calcifying nanobacteria can cause black pigment gallstones
This article was originally published in Clinica
Executive Summary
In what looks certain to boost the prospects of US firm Nanobac Pharmaceuticals - developer of nanobacteria-based diagnostics - a study has shown for the first time that black pigment gallstones could be promoted by nanobacterial infection. The firm now has plans to extend its product portfolio into this new market.